|Articles|December 1, 2015
- Applied Clinical Trials-05-01-2013
- Volume 22
- Issue 5
Applied Clinical Trials Digital Edition - May 2013
Subject Recruitment: The Ideas Initiative Trial Design: Early Phase CNS Drug Liabilities; Improving Enrollment Forecasts Also in this issue: Update on Europe's Clinical Trial Rules Debate Public Perception of Clinical Research Clinical Trial Barriers
Advertisement
Articles in this issue
over 13 years ago
The IDEAS Initiativeover 13 years ago
Sponsors and Service Providers Share Their Experiencesover 13 years ago
Optimizing Efficiencyover 13 years ago
Principal Investigators Take the Lead FDA-Regulated Studiesover 13 years ago
Improving Clinical Trial Enrollment Forecasts Using SORMover 13 years ago
Breaking Down Clinical Barriersover 13 years ago
ACT Coverover 13 years ago
CNS Drug Liabilities in Early Phase Clinical TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
2
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
3
Bridging Data Gaps: Curating Real-World Data for Oncology Research
4
Why Execution Strategy Begins at the Business Decision: Q&A with Elizabeth Walsh, Walsh Clinical Advisory
5